Advertisement
Advertisement

INKT

INKT logo

MiNK Therapeutics, Inc. Common Stock

10.95
USD
Sponsored
-0.05
-0.45%
Aug 07, 15:59 UTC -4
Closed
exchange

After-Market

11.24

+0.29
+2.65%

MiNK Therapeutics, Inc. Common Stock Profile

About

MiNK Therapeutics Inc. is a clinical stage biotechnology company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T cell therapies to treat cancer and other immune-mediated diseases. MiNK Therapeutics Inc. is headquartered in New York.

Info & Links

CEO

Jennifer S. Buell

Headquarters

149 Fifth Avenue, Suite 500
New York, NY 10010, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.minktherapeutics.com

Auditor

KPMG LLP

Share holders

376

Employees

15

MiNK Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

56M

Enterprise Value

46.47M

Enterprise Value/EBITDA(ttm)

-3.67

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

78.10%

Return on Assets(ttm)

-118.57%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-12.66M

Net Income Available to Common(ttm)

-12.47M

Diluted EPS(ttm)

-2.84

Share Statistics

Beta (5Y Monthly)

0.48

52-Week Change

-13.51%

S&P 500 52-Week Change

21.41%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

4.98M

Dividend Yield

0.00%

Float4

3.97M

% Held by Insiders

20.40%

% Held by Institutions

2.87%

Balance Sheet

Total Cash(mrq)

9.53M

Total Cash Per Share(mrq)

1.91

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.38%

Quick Ratio(mrq)

1.38%

Book Value Per Share(mrq)

-2.55

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.36

Free Cash Flow(ytd)

-1.73M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement